Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular Lenses
Primary Purpose
Cataract, Intraocular Lens Opacification
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
RayOne® Hydrophobic lens 800C
RayOne® Hydrophilic lens 600C
Sponsored by
About this trial
This is an interventional treatment trial for Cataract
Eligibility Criteria
Inclusion Criteria:
- Unilateral or bilateral cataracts requiring surgical intervention
- Age over 18 years
- Able to understand informed consent and the objectives of the trial
- Not pregnant, not breast feeding
- No previous eye surgery
- Corneal astigmatism less than 1 diopter in both eyes.
Exclusion Criteria:
- age-related macula degeneration
- glaucoma
- previous retinal vascular disorders
- previous retinal detachment or tear
- any neuro-ophthalmological condition
- any inherited retinal disorder or pathology
- previous strabismus surgery or record of amblyopia
- previous TIA, CVA or other vaso-occlusive disease
- already enrolled in another study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
RayOne® Hydrophilic lens 600C
RayOne® Hydrophobic lens 800C
Arm Description
Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophilic lens 600C
Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophobic lens 800C
Outcomes
Primary Outcome Measures
Posterior Capsular Opacification of Intraocular Lens
Degree of the Posterior Capsular Opacification of Intraocular Lens will be assessed using digital imaging techniques
Intraocular lens glistenings
Degree of the intraocular lens glistenings will be quantified using digital analysis
Intraocular lens tilt and decentration
Secondary Outcome Measures
Visual Acuities
Unaided and Best corrected Logmar Visual acuity for distance, and for near vision will be assessed
Forward light scatter and Contrast Sensitivity Measurement
Forward light scatter and Contrast Sensitivity Measurement will be quantified using computerised visual testing
Patient Satisfaction
Validated questionnaires will be used to assess patient satisfaction
Intraoperative and post operative complications
Full Information
NCT ID
NCT04122664
First Posted
October 8, 2019
Last Updated
October 9, 2019
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborators
City, University of London, King's College London
1. Study Identification
Unique Protocol Identification Number
NCT04122664
Brief Title
Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular Lenses
Official Title
Prospective Randomized Controlled Study Measuring Posterior Capsular Opacification, Lens Glistenings, Tilt and Decentration, and Visual Outcomes Following Insertion of the RayOne Hydrophobic Lens 800C and the RayOne Hydrophilic Lens 600C.
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
October 14, 2019 (Anticipated)
Primary Completion Date
May 2022 (Anticipated)
Study Completion Date
May 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborators
City, University of London, King's College London
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
A prospective randomized controlled clinical study to measure posterior capsular opacification, objective measurement of glistenings and intraocular lens tilt and decentration as well as visual outcomes following insertion of a monofocal, aspheric, hydrophobic acrylic intraocular lens: the RayOne® Hydrophobic lens 800C and a monofocal aspheric, hydrophilic acrylic intraocular lens: the RayOne® Hydrophilic lens 600C
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Intraocular Lens Opacification
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Patients randomised into one of two groups
Allocation
Randomized
Enrollment
176 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
RayOne® Hydrophilic lens 600C
Arm Type
Active Comparator
Arm Description
Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophilic lens 600C
Arm Title
RayOne® Hydrophobic lens 800C
Arm Type
Active Comparator
Arm Description
Patients will be randomly selected to receive the monofocal, acrylic, RayOne® Hydrophobic lens 800C
Intervention Type
Device
Intervention Name(s)
RayOne® Hydrophobic lens 800C
Intervention Description
Patients will receive a monofocal, aspheric, hydrophobic acrylic intraocular lens: the RayOne® Hydrophobic lens 800C
Intervention Type
Device
Intervention Name(s)
RayOne® Hydrophilic lens 600C
Intervention Description
Patients will receive a monofocal aspheric, hydrophilic acrylic intraocular lens: the RayOne® Hydrophilic lens 600C.
Primary Outcome Measure Information:
Title
Posterior Capsular Opacification of Intraocular Lens
Description
Degree of the Posterior Capsular Opacification of Intraocular Lens will be assessed using digital imaging techniques
Time Frame
24 months
Title
Intraocular lens glistenings
Description
Degree of the intraocular lens glistenings will be quantified using digital analysis
Time Frame
24 months
Title
Intraocular lens tilt and decentration
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Visual Acuities
Description
Unaided and Best corrected Logmar Visual acuity for distance, and for near vision will be assessed
Time Frame
24 months
Title
Forward light scatter and Contrast Sensitivity Measurement
Description
Forward light scatter and Contrast Sensitivity Measurement will be quantified using computerised visual testing
Time Frame
24 months
Title
Patient Satisfaction
Description
Validated questionnaires will be used to assess patient satisfaction
Time Frame
24 months
Title
Intraoperative and post operative complications
Time Frame
0 days-24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Unilateral or bilateral cataracts requiring surgical intervention
Age over 18 years
Able to understand informed consent and the objectives of the trial
Not pregnant, not breast feeding
No previous eye surgery
Corneal astigmatism less than 1 diopter in both eyes.
Exclusion Criteria:
age-related macula degeneration
glaucoma
previous retinal vascular disorders
previous retinal detachment or tear
any neuro-ophthalmological condition
any inherited retinal disorder or pathology
previous strabismus surgery or record of amblyopia
previous TIA, CVA or other vaso-occlusive disease
already enrolled in another study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Khayam Naderi, MBBS BSc MA
Phone
020 7188 7188
Ext
84331
Email
khayam.naderi@gstt.nhs.uk
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Posterior Capsular Opacification and Glistenings in Hydrophobic and Hydrophilic Intraocular Lenses
We'll reach out to this number within 24 hrs